XRAY
31
-3
TGNA
48
-2
NAVI
55
-2
BBY
56
-2
HSY
40
2
NSC
62
-5
MAT
51
-3
NEM
48
2
DHI
53
-3
WEC
45
2
LEG
27
-2
HRL
30
-5
MAS
67
-3
WAT
54
2
DUK
64
2
BAX
30
-3
CMG
51
-3
EQR
54
-2
MLM
53
-5
ADM
33
-3
XRAY
31
-3
TGNA
48
-2
NAVI
55
-2
BBY
56
-2
HSY
40
2
NSC
62
-5
MAT
51
-3
NEM
48
2
DHI
53
-3
WEC
45
2
LEG
27
-2
HRL
30
-5
MAS
67
-3
WAT
54
2
DUK
64
2
BAX
30
-3
CMG
51
-3
EQR
54
-2
MLM
53
-5
ADM
33
-3
Financhill
Back

SLR Investment Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
10

SLRC
SLR Investment

Last Price:
15.08
Seasonality Move:
-1.32%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
10
SLR Investment (SLRC) is a Sell

Is SLR Investment a Buy, Sell or Hold?

  • The current SLR Investment [SLRC] share price is $15.06. The Score for SLRC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • SLRC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SLRC Stock Price Chart

What is SLR Investment's stock price today?

  • The SLR Investment share price today is $15.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLRC is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SLRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 35.73 Sell
Chaikin Money Flow: -102226 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.27 - 15.73) Sell
Bollinger Bands (100): (15.37 - 16.27) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SLRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.31 Sell
20-day SMA: 15.53 Sell
50-day SMA: 15.54 Sell
200-day SMA: 15.49 Sell
8-day EMA: 15.27 Sell
20-day EMA: 15.41 Sell
50-day EMA: 15.54 Sell
200-day EMA: 15.49 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

SLR Investment Earnings Growth & SLRC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.05 per share, and a decrease next year of $0.10 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

SLR Investment Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):